Cannula Market

Cannula Market Overview:

The global cannula market size reached USD 168.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 278.8 Million by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033. North America represents the largest regional market owing to the rising healthcare costs and high prevalence of chronic illnesses requiring medical interventions. Furthermore, the market is driven by the growing need for life-saving techniques like fluid resuscitation and quick medicine delivery to treat heart strokes, rising demand for long-term care institutions and home healthcare services, and thriving medical tourism industry.

Cannula Market Analysis:

• Major Market Drivers: The rising prevalence of cardiovascular diseases around the world is supporting the growth of the market.
• Key Market Trends: The growing aging population that is highly susceptible to chronic illnesses is offering a favorable market outlook.
• Geographical Trends: North America enjoys the leading position on account of its sophisticated healthcare system and rising healthcare costs.
• Competitive Landscape: Some of the major market players in the cannula industry include Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith & Nephew PLC, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated, Terumo Corporation, among many others.
• Challenges and Opportunities: While the market faces challenges, such as stringent regulatory requirements and high competition, it also encounters opportunities in technological advancements and expanding healthcare infrastructure in emerging markets.

Cannula Market Trends:

Growing Need for Minimally Invasive Procedures

The cannula market is growing at a very fast rate due to the increasing number of medical professionals incorporating minimally invasive procedures. The procedures are decreasing patient recovery time and minimizing the risk of complications compared to conventional surgeries. As patients become more willing to look for solutions that offer quicker recovery and fewer side effects, medical centers are progressively using cannulas for various procedures. Cannulas are now used for administering drugs, conducting biopsies, and gaining access to veins and arteries. Such procedures are increasingly prevalent in the fields of oncology, cardiology, and cosmetic surgeries. As technology advances, cannulas are being refined continuously to achieve more precision and safety for patients, creating additional demand. The transition of the healthcare sector towards ambulatory and outpatient care is also supporting the cannula market as such treatments necessitate the use of these devices. IMARC Group predicts that the global minimally invasive surgery market is projected to attain USD 94.9 Billion by 2033.

Cannula Design Technology

Technology advancements in cannula design are also constantly evolving and enhancing the design of cannulas, which is largely fueling the market growth. New materials and designs are being incorporated to increase the safety, comfort, and performance of these devices. For instance, cannulas are now being designed with flexible and biocompatible materials that minimize patient discomfort and reduce the risk of complications like infection or blood clots. Moreover, novel features such as self-sealing mechanisms and enhanced ergonomic designs are facilitating easier insertion of the cannulas by medical professionals with higher accuracy. The application of micro-cannulas is increasingly being adopted, especially in cosmetic and dermatology interventions, because they can minimize bruising and enhance accuracy. With these designs improving and becoming more accepted in clinical procedures, the market for cannulas is growing, motivated by the need for safer and more efficient medical devices. In 2024, Auxein, a worldwide frontrunner in orthopaedic products, revealed the remarkable success of its involvement in MEDICA 2024, held from November 11-14 in Düsseldorf, Germany. Featuring more than 5,800 exhibiting companies from 72 countries, presenting their expertise to approximately 80,000 trade visitors (from 165 nations), MEDICA reaffirmed its status as one of the globe's largest and most esteemed medical technology trade fairs, with Auxein's presence being a significant highlight. Auxein introduced a diverse array of cutting-edge Orthopedic and Arthroscopy Products at MEDICA 2024, featuring several AV-Wiselock Plates, Auxilock Silicon Cannula, Auxilock Rigid Threaded Cannula, a second Reusable Suture Passer, Knee Escorpian Suture Passer, Bioabsorbable Interference screw, the GFS Ultimate Button with Brace/Tape System, among others.

Increasing Incidence of Chronic Diseases

The increased prevalence of chronic diseases, including cardiovascular diseases, diabetes, and cancer, is driving the demand for cannulas. As the world's population ages, there is a growing demand for medical devices that can be used in the long-term treatment and management of these conditions. Cannulas are commonly employed for intravenous access, administration of drugs, and constant blood sampling in chronic disease patients. Since patients with chronic diseases tend to need ongoing treatments like chemotherapy, dialysis, or insulin injection, the use of cannulas is becoming increasingly popular. The increasing need for such treatments is motivating clinicians to use cannulas for faster and better treatment. Moreover, the occurrence of such diseases is on the rise globally, making the healthcare industry invest in devices like cannulas that may aid in controlling these disorders with little discomfort and complications. Apart from this, the rise in geriatric populations, prone to various chronic ailments like cardiovascular complications are catalyzing the need for cannulas. As per an article by the World Health Organization (WHO), the number of people aged 60 years and above are expected to reach 1.4 billion by 2030 and 2.1 billion by 2050.

Cannula Market Growth Drivers:

Growing Demand for Cosmetic Procedures

The growing popularity of cosmetic procedures and dermatological treatments is catalyzing the demand for the cannula market. Techniques like fat grafting, liposuction, and non-surgical facial treatments now depend more on the application of cannulas, especially those with smaller diameters and high flexibility. These instruments are contributing towards refining the accuracy and safety of these cosmetic procedures, which are gaining popularity among patients. Specifically, the non-surgical aesthetic procedures trend, including the use of dermal filler injections, is on the rise with the cannula gaining traction over conventional needles because of its lower risk of bruising and complications. As more people turn to cosmetic treatments, the market for cannulas expands as medical aesthetics advances and people want minimally invasive procedures with natural-looking outcomes but without much downtime.

Government Initiatives and Healthcare Investments

Government policies and rising healthcare expenditure are major drivers supporting the growth of the cannula market. Most governments are giving high priority to the development of healthcare infrastructure and increasing access to quality healthcare, especially in emerging economies. As healthcare budgets rise, governments are releasing more funds for the purchase of medical devices, such as cannulas, in order to enhance patient care. Furthermore, regulatory agencies are ensuring that medical devices are of high safety and quality to build trust and demand among healthcare professionals as well as patients. Public health initiatives in disease prevention and treatment are also driving the adoption of medical devices such as cannulas for improved chronic care, increasing their market uptake. In areas with developing healthcare sectors, demand for cannulas is witnessing fast growth owing to such efforts.

Increasing Awareness About Infection Control and Safety

Increasing awareness regarding infection control and safety norms in healthcare environments is helping propel demand for cannulas. As hospitals and clinics become more concerned about patient safety, they are increasingly incorporating medical equipment that helps prevent the risk of infection and complications. The utilization of one-time use cannulas and the implementation of new technologies that provide sterile environments are becoming standard procedures in order to improve patient safety. With increasing awareness of the need for upkeep of sterile environments and the avoidance of healthcare-associated infections (HAIs), medical practitioners are giving preference to the utilization of disposable, pre-sterile cannulas for procedures. This change is especially significant in settings such as intensive care units (ICUs) and surgical theaters, where the threat of infection is greater. Increased attention to infection control is bolstering cannula market growth as hospitals and healthcare professionals invest in safer, more effective medical equipment.

Cannula Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product, type, size, material, application, and end-user.

Breakup by Product:

• Cardiac Cannulas
• Nasal Cannulas
• Vascular Cannulas
• Dermatology Cannulas
• Arthroscopy Cannulas
• Others
   

Cardiac cannulas account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes cardiac cannulas, nasal cannulas, vascular cannulas, dermatology cannulas, arthroscopy cannulas, and others. According to the report, cardiac cannulas represent the largest segment.

Because they are essential for heart surgeries and treatments, cardiac cannulas are the most common product category in the market. Specialty cannulas such as these are designed specifically to access and manipulate the heart during cardiac surgeries, coronary artery bypass grafting (CABG), and valve replacements. They aid in ensuring that medications, fluids, and anesthesia are accurately administered to the heart during surgeries and enable effective drainage and irrigation. The need for cardiac cannulas is increasing dramatically due to the rising incidence of cardiovascular disorders around the world and improvements in surgical methods that favor less invasive procedures.

Breakup by Type:

• Neonatal Cannulas
• Straight Cannulas
• Winged Cannula
• Wing with Port Cannula
• Others
   

Straight cannulas hold the largest share of the industry

A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes neonatal cannulas, straight cannulas, winged cannula, wing with port cannula, and others. According to the report, straight cannulas account for the largest market share.

The market for cannulas has seen a rise in the number of straight cannulas, mostly because of their broad range of medical procedure applications. The simple form of these cannulas makes it possible to implant them easily and transport gases, liquids, and prescriptions into the body precisely. They are frequently utilized in diagnostic procedures, blood transfusions, and intravenous (IV) therapy, where simple access and fluid delivery are critical. Because they can be quickly deployed and consistently give essential care, straight cannulas are the preferable option in emergency situations. Additionally, because of their accessibility, affordability, and simplicity, healthcare facilities around the world find them intriguing.

Breakup by Size:

• 14G
• 16G
• 18G
• 20G
• 22G
• 24G
• 26G
   

18G represents the leading market segment 

The report has provided a detailed breakup and analysis of the market based on the size. This includes 14G, 16G, 18G, 20G, 22G, 24G, and 26G. According to the report, 18G represents the largest segment.

18G (Gauge) cannulas are the most popular size category in the market due to their extensive and adaptable use in medical operations. These 18G diameter cannulas are ideal for a range of applications because they balance fluid flow rate and patient comfort. They are frequently used in blood transfusions, where effective flow is crucial, and intravenous (IV) therapy for the administration of drugs and fluids. The 18G size is also preferred in emergency medicine since it can administer medications fast in life-threatening circumstances.

Breakup by Material:

• Plastic (PVC) Cannulas
• Silicone Cannulas
• Metal Cannulas (Stainless Steel)
   

Plastic (PVC) cannulas exhibit a clear dominance in the market 

A detailed breakup and analysis of the market based on the material have also been provided in the report. This includes plastic (PVC) cannulas, silicone cannulas, and metal cannulas (stainless steel). According to the report, plastic (PVC) cannulas account for the largest market share.

Because of their broad use and numerous healthcare applications, plastic (PVC) cannulas are becoming the most popular material type in the cannula industry. PVC cannulas are preferred because they are adaptable, reasonably priced, and suitable for a variety of medical operations. As they can maintain sterile conditions and guarantee patient comfort, they are frequently employed in intravenous (IV) therapy for the administration of fluids and medicine delivery. PVC cannulas are also widely used in blood collection because of their flat surface, which makes sample collection and blood flow more efficient, thereby contributing to the cannula market size. They are appropriate for both long-term use in chronic care settings and short-term therapies due to their lightweight and sturdy design.

Breakup by Application:

• Cardiovascular Surgery
• Oxygen Therapy
• General Surgery
• Cosmetic/Plastic Surgery
• Orthopedic Surgery
• Others 
   

The report has provided a detailed breakup and analysis of the market based on the application. This includes cardiovascular surgery, oxygen therapy, general surgery, cosmetic/plastic surgery, orthopedic surgery, and others.

Because cardiovascular disorders are becoming more commonplace worldwide, there is a substantial need for cannulas in the cardiovascular surgery industry. The cardiac cannulas used in CABG and valve replacement surgeries, among other surgeries, are essential for accessing and repositioning the heart throughout the procedure. These customized cannulas allow for efficient drainage and irrigation as well as accurate administration of drugs, fluids, and anesthetic to the heart.

Oxygen therapy cannulas represent a significant portion of the market. These cannulas, usually nasal cannulas, are vital for providing patients with respiratory disorders with extra oxygen or for use during surgical procedures, which is positively influencing the cannula market value. For patients in need of both short-term and long-term oxygen therapy, they offer a convenient and effective way to administer oxygen. The need for oxygen therapy cannulas is still high due to the rise in respiratory illnesses and oxygenation-related ailments, as well as the development in technology that improve patient comfort and treatment effectiveness.

Within the field of general surgery, cannulas are utilized for a variety of functions, such as IV treatment, during different surgical procedures. Cannulas are used in general surgery to allow precise access for therapeutic and diagnostic treatments, as well as to assist the introduction of fluids, medicines, and anesthetics. Their dependability and adaptability make them essential for both elective and emergency surgeries, which contributes to their consistent demand in medical facilities across the globe.

Breakup by End-User:

• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Others
   

Hospitals are the predominant market segment

A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes hospitals, ambulatory surgery centers (ASCs), and others. According to the report, hospitals account for the largest market share.

Due to their critical position as primary healthcare providers and locations for medical procedures, hospitals stand out as the largest end-user category in the market. Intensive care units (ICUs), regular patient wards, surgery, and emergency departments are just a few of the areas in hospitals where cannulas are essential to daily operations. They enable the accurate and effective delivery of fluids and drugs to patients during intravenous (IV) therapy, medication administration, blood transfusions, and surgical procedures. The strong demand for cannulas is maintained by the sheer volume of medical treatments carried out in hospitals as well as the rising prevalence of surgical procedures and chronic disorders.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

North America leads the market, accounting for the largest cannula market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for cannula.

Because of its sophisticated healthcare system, rising healthcare costs, and high prevalence of chronic illnesses requiring medical interventions, North America leads the world in cannula sales. Extensive research and development (R&D) efforts supporting the region's dominance are resulting in ongoing advancements in medical equipment, including cannulas. The need for cannulas in a variety of medical specialties, including cardiology, oncology, and emergency medicine, is fueled by the fact that North American healthcare facilities, especially those in the United States and Canada, place a high priority on patient safety, efficiency, and quality of service. Adoption of new medical technologies, such as cannulas, in clinical practice is further supported by advantageous reimbursement policies and strong healthcare laws, thereby propelling the cannula market growth. There is an increasing need for cannula-based surgical operations and medical therapies as the aging population and the prevalence of chronic diseases are rising. Moreover, key players operating the region are focusing on getting patent approvals for their products. For instance, in 2023, Inspira™ Technologies OXY B.H.N. Ltd. announced that the novel convertible dual lumen cannula device and method of use, being developed for the INSPIRA™ ART System, has been granted a patent by the U.S. Patent and Trademark Office (USPTO).

Competitive Landscape:

• The cannula market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the cannula industry include Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith & Nephew PLC, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated, and Terumo Corporation.

  (Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

• Major firms in the industry are actively taking part in a number of strategic projects aimed at bolstering their market shares and promoting expansion. In order to innovate and improve cannula designs and increase patient comfort, safety, and efficacy, these companies are making significant investments in research and development (R&D) activities. To meet the needs of developing healthcare markets and a variety of medical applications, they are also diversifying their product lines. Cannula companies frequently engage in strategic alliances, mergers, and acquisitions to expand their technological prowess and consumer base. For instance, in 2024, BD (Becton, Dickinson and Company) announced a definitive agreement under which BD will acquire Edwards' Critical Care product group ("Critical Care"), a global leader in advanced monitoring solutions, for $4.2 billion in cash. Top companies are also concentrating on geographical growth into developing countries to take advantage of the rising demand for cutting-edge medical products in these areas. To boost knowledge and uptake of their goods, marketing campaigns and educational initiatives targeted at healthcare professionals are also given top priority, which is increasing the cannula market revenue.

Cannula Market News:

• May 2025: Vapotherm, Inc., the worldwide frontrunner in noninvasive respiratory support without masks, is pleased to announce the release of a new clinical study, Effect of Single-Prong Cannula Design with High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates, in Critical Care Explorations. The research shows that the ProSoft® Unicorn™ Cannula, a single-prong high velocity therapy tool, offers similar relief from dyspnea at much lower flow rates when compared to conventional dual-prong cannulas.
• April 2025: The HF3 (High-Flow Nasal Cannula Respiratory Humidifiers) created by Northern Meditec has recently received the EU Medical Device Regulation (MDR) certification. This significant achievement demonstrates that Northern Meditec’s product quality, safety, and performance meet the rigorous standards of the European market, while also establishing a strong base for further growth in the international market. On April 30, 2025, the Northern Meditec High-Flow Nasal Cannula Respiratory Humidifiers (HF3) successfully cleared the rigorous assessment by the SGS FIMKO OY Notified Body 0598 and received the quality management system certification in accordance with the EU Medical Device Regulation (EU) 2017/745 Annex IX.
• February 2025: ClearPoint Neuro, Inc., a worldwide company focused on devices, cells, and gene therapies that provide accurate navigation for the brain and spine, today revealed it has obtained European Medical Device Regulation (EU MDR) approval for the SmartFlow Neuro Cannula. The SmartFlow Cannula was initially approved under the Medical Device Directive 93/42/EEC (MDD) and has now attained the more stringent EU MDR certification well before the 2027 deadline for Class III devices. Furthermore, the revised certification has prolonged the SmartFlow Cannula's shelf life to 48 months within the European Union (EU), up from the previous shelf life of 24 months.
• February 2025: Airglove Medical, located in East Kilbride, has secured £500,000 in equity funding from primary investor Pulse Angels and co-investor Scottish Enterprise to support the market introduction of its patented Airglove device designed to assist healthcare professionals in cannulating patients on the first attempt.
• January 2025: Terumo Corporation revealed the worldwide introduction of the Terumo Injection Filter Needle, marking the initial phase of the INFINO™ -Development Program. Designed for both hypodermic and intravitreal injections, the Injection Filter Needle incorporates a built-in polyamide 5-micrometer mesh filter to block particles from being injected. The Terumo Injection Filter Needle includes an ultra-thin-walled cannula. Terumo K-Pack 30G needles equipped with a similar ETW-cannula exhibit over four times the flow rate compared to standard wall options.
• November 2024: ClearPoint Neuro, Inc., a worldwide platform company facilitating therapy through brain navigation and delivery, today revealed that the U.S. Food and Drug Administration (FDA) has approved marketing for the SmartFlow Neuro Cannula via the De Novo pathway. The SmartFlow Neuro Cannula is designed for the intraputaminal delivery of PTC Therapeutics' gene therapy KEBILIDI™ (eladocagene exuparvovec-tneq) to treat aromatic L-amino acid decarboxylase (AADC) deficiency.

Cannula Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, cannula market forecasts, and dynamics of the market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the global market.
• The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
• Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the cannula industry and its attractiveness.
• The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.